Magnitude of rise in proneurotensin is related to amount of triglyceride appearance in blood after standardized oral intake of both saturated and unsaturated fat

[1]  O. Melander,et al.  The association between plasma proneurotensin and glucose regulation is modified by country of birth , 2019, Scientific Reports.

[2]  M. Budoff,et al.  Atherosclerosis: Pathophysiology of insulin resistance, hyperglycemia, hyperlipidemia, and inflammation , 2019, Journal of diabetes.

[3]  G. Silecchia,et al.  Increased Plasma Proneurotensin Levels Identify NAFLD in Adults With and Without Type 2 Diabetes , 2018, The Journal of clinical endocrinology and metabolism.

[4]  O. Melander,et al.  Proneurotensin Predicts Cardiovascular Disease in an Elderly Population , 2018, The Journal of clinical endocrinology and metabolism.

[5]  G. Silecchia,et al.  Neurotensin Is a Lipid-Induced Gastrointestinal Peptide Associated with Visceral Adipose Tissue Inflammation in Obesity , 2018, Nutrients.

[6]  M. Camilleri,et al.  Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis. , 2018, Gastroenterology.

[7]  J. Henzen.  Publisher's note , 1979, Brain Research.

[8]  O. Melander,et al.  An obligatory role for neurotensin in high fat diet-induced obesity , 2016, Nature.

[9]  F. Bäckhed,et al.  Neurotensin Is Coexpressed, Coreleased, and Acts Together With GLP-1 and PYY in Enteroendocrine Control of Metabolism. , 2016, Endocrinology.

[10]  Z. Halpern,et al.  Sortilin deficiency improves the metabolic phenotype and reduces hepatic steatosis of mice subjected to diet-induced obesity. , 2015, Journal of hepatology.

[11]  [The Helsinki Declaration of the World Medical Association (WMA). Ethical principles of medical research involving human subjects]. , 2014, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

[12]  P. Almgren,et al.  Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality. , 2012, JAMA.

[13]  Ž. Reiner,et al.  Dyslipidemias in the Prevention of Cardiovascular Disease: Risks and Causality , 2012, Current Cardiology Reports.

[14]  L. Berglund,et al.  Postprandial Lipoproteins and Cardiovascular Disease Risk in Diabetes Mellitus , 2010, Current diabetes reports.

[15]  P. Ridker,et al.  Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. , 2007, JAMA.

[16]  A. Bergmann,et al.  Proneurotensin 1–117, a stable neurotensin precursor fragment identified in human circulation , 2006, Peptides.

[17]  B. Swinburn,et al.  Effect of orlistat on cardiovascular disease risk in obese adults , 2005, Diabetes, obesity & metabolism.

[18]  A. Gottsäter,et al.  Decreasing levels of tumour necrosis factor α and interleukin 6 during lowering of body mass index with orlistat or placebo in obese subjects with cardiovascular risk factors , 2003, Diabetes, obesity & metabolism.

[19]  A. Gottsäter,et al.  Decreasing levels of tumour necrosis factor alpha and interleukin 6 during lowering of body mass index with orlistat or placebo in obese subjects with cardiovascular risk , 2003 .

[20]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[21]  R. Carraway,et al.  Endogenous neurotensin facilitates enterohepatic bile acid circulation by enhancing intestinal uptake in rats. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[22]  E. Richelson,et al.  Neurotensin: peptide for the next millennium , 2000, Regulatory Peptides.

[23]  S. Yusuf,et al.  The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. , 1999, Diabetes care.

[24]  S. Kamal.  Radioimmunoassay and related techniques. , 1993, JPMA. The Journal of the Pakistan Medical Association.

[25]  P. Emson,et al.  The regional distribution of neurotensin-like immunoreactivity in central and peripheral tissues of the cat , 1983, Brain Research.

[26]  R. Carraway,et al.  NEUROTENSIN: DISCOVERY, ISOLATION, CHARACTERIZATION, SYNTHESIS AND POSSIBLE PHYSIOLOGICAL ROLES * , 1982, Annals of the New York Academy of Sciences.

[27]  P. Fu,et al.  Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.

[28]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.